Samsung Bioepis Breaks Down Biosimilar Experiences In Europe And US

'Both Markets Require Rigorous Standards For Approval'

US-EU-Flags_169048001_1200.jpg
Samsung Bioepis has launched five biosimilars in Europe • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products